In last trading session, Entero Therapeutics Inc. (NASDAQ:ENTO) saw 1.19 million shares changing hands with its beta currently measuring 1.35. Company’s recent per share price level of $0.56 trading at $0.11 or 24.14% at ring of the bell on the day assigns it a market valuation of $1.82M. That closing price of ENTO’s stock is at a discount of -2491.07% from its 52-week high price of $14.51 and is indicating a premium of 66.07% from its 52-week low price of $0.19. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.45 million shares which gives us an average trading volume of 765.22K if we extend that period to 3-months.
Entero Therapeutics Inc. (NASDAQ:ENTO) trade information
Upright in the green during last session for gaining 24.14%, in the last five days ENTO remained trading in the green while hitting it’s week-highest on Wednesday, 10/16/24 when the stock touched $0.56 price level, adding 12.5% to its value on the day. Entero Therapeutics Inc.’s shares saw a change of -86.67% in year-to-date performance and have moved 33.33% in past 5-day. Entero Therapeutics Inc. (NASDAQ:ENTO) showed a performance of 59.05% in past 30-days. Number of shares sold short was 88686.0 shares which calculate 0.74 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Entero Therapeutics Inc. (ENTO) estimates and forecasts
Statistics highlight that Entero Therapeutics Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -80.69% of value to its shares in past 6 months, showing an annual growth rate of 97.64% while that of industry is 17.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 73.53% during past 5 years.
On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Aug 31, 2024 , the former fund manager was holding 15.34 shares of worth $8586.0 or 0.47% of the total outstanding shares. The later fund manager was in possession of 4.54 shares on Jun 30, 2024 , making its stake of worth around $2538.0 in the company or a holder of 0.14% of company’s stock.
